title: Expression of syndecan in transformed mouse keratinocytes.
abstract: BACKGROUND
  Malignant transformation is frequently associated with altered behavior of cells, a phenomenon that also suggests changes in cell-matrix interactions. We have studied expression of syndecan, a cell surface proteoglycan that binds extracellular matrix components and growth factors, in various chemically transformed mouse keratinocyte cell lines that differ in their morphology and tumorigenicity.
  
  
  METHODS
  A monoclonal antibody, specific for mouse syndecan, and a cDNA clone for mouse syndecan, were used to detect syndecan in seven different keratinocyte cell lines. The glycosaminoglycan composition of syndecan was studied using differential digestions of heparan sulfate and chondroitin sulfate chains.
  
  
  RESULTS
  In general, the tumorigenic cells were found to express lower amounts of syndecan, both at protein and mRNA levels, than the nontumorigenic cells. The most tumorigenic cell line CarC revealed barely detectable syndecan expression. Also, molecular polymorphism of syndecan was observed, as three forms of syndecan with different molecular weights appeared on the surfaces of different keratinocytes. The highly tumorigenic cells, that expressed low amounts of syndecan, expressed syndecan with the largest molecular weight. The different molecular weights were shown to reflect an increased amount of both heparan and chondroitin sulfate chains attached to the core protein. An increased shedding of syndecan ectodomain from the membrane-associated domain was observed in cells that express high amounts of mutated Ha-ras p21.
  
  
  CONCLUSIONS
  The results suggest, that transformed epithelial cells can modulate the appearance of syndecan on the cell-surface by at least two ways: (a) by altering its glycosylation or (b) by increasing its shedding from the cell surface. These modulations, together with overall suppression of syndecan expression, could be associated with malignant transformation of keratinocytes.
authors.affiliation: Department of Medical Biochemistry, University of Turku, Finland.
authors.forename: P
authors.initials: P
authors.lastname: Inki
authors.forename: M
authors.initials: M
authors.lastname: Gomez
authors.forename: M
authors.initials: M
authors.lastname: Quintanilla
authors.forename: A
authors.initials: A
authors.lastname: Cano
authors.forename: M
authors.initials: M
authors.lastname: Jalkanen
mesh_terms: D000818:Animals; D002461:Cell Line, Transformed / Q000378:metabolism*; D005455:Fluorescent Antibody Technique; D011905:Genes, ras / Q000502:physiology; D006025:Glycosaminoglycans / Q000032:analysis; D015151:Immunoblotting; D015603:Keratinocytes / Q000378:metabolism*; D008562:Membrane Glycoproteins / Q000096:biosynthesis* / Q000737:chemistry; D051379:Mice; D008970:Molecular Weight; D011509:Proteoglycans / Q000096:biosynthesis* / Q000737:chemistry; D053667:Syndecans
chemical_list: D006025:Glycosaminoglycans; D008562:Membrane Glycoproteins; D011509:Proteoglycans; D053667:Syndecans